Human myeloma cells shed the interleukin-6 receptor: Inhibition by tissue inhibitor of metalloproteinase-3 and a hydroxamate-based metalloproteinase inhibitor

British Journal of Haematology

Volumn 101, Issue 4, 1998, Pages 694-702

  Hargreaves, Philip G ^a   Wang, Fengfei ^a   Antcliff, Jennifer ^a   Murphy, Gillian ^b   Lawry, John ^a   Russell, R Graham G ^a   Croucher, Peter I ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

Metalloproteinase; Multiple myeloma; Shedding; Soluble interleukin 6 receptor; Tissue inhibitor of metalloproteinase 3

Indexed keywords

ACTINONIN; BATIMASTAT; BENZAMIDINE; CYSTEINE PROTEINASE INHIBITOR; DIMETHYL SULFOXIDE; HYDROXAMIC ACID; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; LEUPEPTIN; METALLOPROTEINASE INHIBITOR; N [N (3 CARBOXYOXIRANE 2 CARBONYL)LEUCYL]AGMATINE; PHORBOL 13 ACETATE 12 MYRISTATE; PHOSPHORAMIDON; PROTEINASE INHIBITOR; SERINE PROTEINASE INHIBITOR; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TISSUE INHIBITOR OF METALLOPROTEINASE 3; UNCLASSIFIED DRUG;

ARTICLE; BONE MARROW CELL; CONTROLLED STUDY; HUMAN; HUMAN CELL; MULTIPLE MYELOMA; MYELOMA CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION;

BONE MARROW CELLS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MULTIPLE MYELOMA; PHENYLALANINE; PROTEASE INHIBITORS; RECEPTORS, INTERLEUKIN-6; TETRADECANOYLPHORBOL ACETATE; THIOPHENES; TISSUE INHIBITOR OF METALLOPROTEINASE-3; TUMOR CELLS, CULTURED;

EID: 0031802915     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1998.00754.x     Document Type: Article

References (42)

1. Anderson, K.C., Jones, R.M., Morimoto, C., Leavitt, P. & Barut, B. (1989) Response patterns of purified myeloma cells to hematopoietic growth factors. Blood, 73, 1915-1924.
2. Arribas, J., Coodly, L., Vollmer, P., Kishimoto, T.K., Rose-John, S. & Massague, J. (1996) Diverse cell surface protein ectodomains are shed by a system sensitive to metalloproteinase inhibitors. Journal of Biological Chemistry, 271, 11376-11382.
3. Bennett, T.A., Lynam, E.B., Sklar, L.A. & Rogelj, S. (1996) Hydroxamate-based metalloproteinase inhibitor blocks shedding of L-selectin adhesion molecule from leukocytes: functional consequences for neutrophil aggregation. Journal of Immunology, 156, 3093-3097.
4. Black, R.A., Rauch, C.T., Kozlosky, C.J., Peschon, J.J., Slack, J.L., Wolfson, M.F., Castner, B.J., Stocking, K.L., Reddy, P., Srinivasan, S., Nelson, N., Boiani, N., Schooley, K.A., Gerhart, M., Davis, R., Fitzner, J.N., Johnson, R.S., Paxton, R.J., March, C.J. & Cerretti, D.P. (1997) A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells. Nature, 385, 729-733.
5. Caligaris-Cappio, F., Bergui, L., Gregoretti, M.G., Gaidano, G., Gaboli, M., Schena, M. & Zallone, A.Z. & Marchisio, P.C. (1989) Role of bone marrow stromal cells in the growth of human multiple myeloma. Blond, 77, 2688-2694.
6. Crowe, P.D., Walter, B.N., Mohler, K.M., Otten-Evans, C., Black, R.A. & Ware, C.F. (1995) A metalloproteinase inhibitor blocks shedding of the 80-kD TNF receptor and TNF processing in T lymphocytes. Journal of Experimental Medicine, 181, 1205-1210.
7. Gaillard, J-P., Bataille, R., Brailly, H., Zuber, C., Yasukawa, K., Attal, M., Maruo, N., Taga, T., Kishimoto, T. & Klein, B. (1993) Increased and highly stable levels of functional soluble interleukin-6 receptor in sera of patients with monoclonal gammopathy. European Journal of Immunology, 23, 820-824.
8. Gallea-Robache, S., Morand, V., Millet, S., Bruneau, J-M., Bhatnagar, N., Chouaib, S. & Roman-Roman, S. (1997) A metalloproteinase inhibitor blocks the shedding of soluble cytokine receptors and processing of transmembrane cytokine precursors in human monocytic cells. Cytokine, 9, 340-346.
9. Gearing, A.J.H., Beckett, P., Christodoulou, M., Churchill, M., Clements, J., Davidson, A.H., Drummond, A.H., Galloway, W.A., Gilbert, R., Gordon, J.L., Leber, T.M., Mangan, M., Miller, K., Nayee, P., Owen, K., Patel, S., Thomas, W., Wells, G., Wood, L.M. & Woolley, K. (1994) Processing of tumour-necrosis factor-α precursor by metalloproteinases. Nature, 370, 555-557.
10. Hardin, J., MacLeod, S., Grigorieva, I., Chang, R., Barlogie, B., Xiao, H. & Epstein, J. (1994) Interleukin-6 prevents dexamethasone-induced myeloma cell death. Blood, 84, 3063-3070.
11. Hata, H., Xiao, H., Petrucci, M.T., Woodliff, J., Chang, R. & Epstein, J. (1993) Interleukin-6 gene expression in multiple myeloma: a characteristic of immature tumor cells. Blood, 81, 3357-3364.
12. Hooper, N.M., Karran, E.H. & Turner, A.J. (1997) Membrane protein secretases. Biochemical Journal, 321, 265-279.
13. Kawano, M., Hirano, T. Matsuda, T., Taga, T., Horii, Y., Iwato, K., Asaoku, H., Tang, B., Tanabe, O., Tanaka, H., Kuramoto, A. & Kishimoto, T. (1988) Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas. Nature, 332, 83-85.
14. Kayagaki, N., Kawasaki, A., Ehata, T., Ohmoto, H., Ikeda, S., Inoue, S., Yoshino, K., Okumura, K. & Yagita, H. (1995) Metalloproteinase-mediated release of human Fas ligand. Journal of Experimental Medicine, 182, 1777-1783.
15. Kishimoto, T., Akira, S., Narazaki, M. & Taga, T. (1995) Interleukin-6 family of cytokines and gp130. Blood, 86, 1243-1254.
16. Klein, B. & Bataille, R. (1992) Cytokine network in human multiple myeloma. Hematology/Oncology Clinics of North America, 6, 273-284.
17. Klein, B., Zhang, X., Lu, Z.-Y. & Bataille, R. (1995) Interleukin-6 in human multiple myeloma. Blood, 85, 863-872.
18. Klein, B., Zhang, X., Jourdan, M., Content, J., Houssiau, F., Aarden, L., Piechaczyk, M. & Bataille, R. (1989) Paracrine rather than autocrine regulation of myeloma cell growth and differentiation by interleukin-6. Blood, 73, 517-526.
19. Kyrstsonis, M-C., Dedoussis, G., Baxevanis, C., Stamatelou, M. & Maniatis, A. (1996) Serum interleukin-6 (IL-6) and interleukin-4 (IL-4) in patients with multiple myeloma (MM). British Journal of Haematalogy 92, 420-422.
20. Lokhorst, H.M., Lamme, T., de Smet, M., Klein, S., de Weger, R.A., van Oers, R. & Bloem, A.C. (1994) Primary tumor cells of myeloma patients induce interleukin-6 secretion in long-term bone marrow cultures. Blood, 84, 2269-2277.
21. Lust, J.A., Donovan, K.A., Kline, M.P., Greipp, P.R., Kyle, R.A. & Maihle, N.J. (1992) Isolation of an mRNA encoding a soluble form of the human interleukin-6 receptor. Cytokine, 4, 96-100.
22. Mariani, S.M., Matiba, B., Baumler, C. & Krammer, P.H. (1995) Regulation of cell surface APO-1/Fas (CD95) ligand expression by metalloproteinases. European Journal of Immunology, 25, 2303-2307.
23. McGeehan, G.M., Becherer, J.D., Bast, R.C., Boyer, C.M., Champion, B., Connolly, K.M., Conway, J.G., Furdon, P., Karp, S., Kidao, S., McElroy, A.B., Nichols, J., Pryzwansky, K.M., Schoenen, F., Sekut, L., Truesdale, A., Verghese, M., Warner, J. & Ways, J.P. (1994) Regulation of tumour-necrosis factor-α processing by a metalloproteinase inhibitor. Nature, 370, 558-561.
24. McKie, N., Dallas, D.J., Edwards, T., Apperley, J.F., Russell, R.G.G. & Croucher, P.I. (1996) Cloning of a novel membrane-linked metalloproteinase from human myeloma cells. Biochemical Journal, 318, 459-462.
25. Moss, M.L., Jin, S-L.C., Milla, M.E., Burkhart, W., Carter, H.L., Chen, W-J., Clay, W.C., Didsbury, J.R., Hassier, D., Hoffman, C.R., Kost, T.A., Lambert, M.H., Leesnitzer, M.A., McCauley, P., McGeehan, G., Mitchell, J., Moyer, M., Pahel, G., Rocque, W., Overton, L.K., Schoenen, F., Seaton, T., Su, J-L., Warner, J., Willard, D. & Becherer, D. (1997) Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-α. Nature, 385, 733-736.
26. Mullberg, J., Durie, F.H., Otten-Evans, C., Alderson, M.R., Rose-John, S., Cosman, D., Black, R.A. & Mohler, K.M. (1993) A metalloproteinase inhibitor blocks shedding of the IL-6 receptor and the p60 TNF receptor. Journal of Immunology, 155, 5198-5205.
27. Mullberg, J., Rauch, C.T., Wolfson, M.F., Castner, B., Fitzner, J.N., Otten-Evans, C., Mohler, K.M., Cosman, D. & Black, R.A. (1997) Further evidence for a common mechanism for shedding of cell surface proteins. FEBS Letters, 401, 235-238.
28. Mullberg, J., Schooltink, H., Stoyan, T., Gunther, M., Graeve, L., Buse, G., Mackiewicz, A. & Rose-John, S. (1993) The soluble interleukm-6 receptor is generated by shedding. European Journal of Immunology, 23, 473-480.
29. Nakajima, T., Yamamoto, S., Cheng, M., Yasukawa, K., Hirano, T., Kishimoto, T., Tokunaga, T. & Honda, M. (1992) Soluble interleukin-6 receptor is released from receptor-bearing cell lines in vitro. Japanese Journal of Cancer Research, 83, 373-378.
30. Narazaki, M., Yasukawa, K., Saito, T., Ohsugi, Y., Fukui, H., Koishihara, Y., Yancopoulos, G.D., Taga, T. & Kishimoto, T. (1993) Soluble forms of the interleukin-6 signal-transducing receptor component gp130 in human serum possessing a potential to inhibit signals through membrane-anchored gp130. Blood, 82, 1120-1126.
31. Ohtani, K., Ninomiya, H., Hasegawa, Y., Kobayashi, T., Kojima, H., Nagasawa, T. & Abe, T. (1995) Clinical significance of elevated soluble interleukin-6 receptor levels in the sera patients with plasma cell dyscrasias. British Journal of Haematology, 91, 116-120.
32. Pellat-Deceunynk, C., Amiot, M., Bataille, R., Van Riet, I., Van Camp, B., Omede, P. & Boccadoro, M. (1995) Human myeloma cell lines as a tool for studying the biology of multiple myeloma: a reappraisal 18 years after. Blood, 86, 4001-4002.
33. Preece, G., Murphy, G. & Ager, A. (1993) Metalloproteinase-mediated regulation of L-selectin levels on leukocytes. Journal of Biological Chemistry, 271, 11634-11640.
34. Pulkki, K., Pelliniemi, T-T., Kajamaki, A., Tienhaara, A., Laakso, M. & Lahtinen, R. (1996) Soluble interleukin-6 receptor as a prognostic factor in multiple myeloma. British Journal of Haematology, 92, 370-374.
35. Salvesen, G. & Nagase, H. (1989) Inhibition of proteolytic enzymes. Proteolytic Enzymes: A Practical Approach (ed. by R. J. Beynon and J. S. Bond), pp. 83-104. Oxford University Press.
36. Smith, M.R., Kung, H., Durum, S.K., Colburn, N.H. & Sun, Y. (1997) TIMP-3 induces cell death by stabilizing TNF-α receptors on the surface of human colon carcinoma cells. Cytokine, 9, 770-780.
37. Smith, S.R. & Morgan, L. (1996) Clinical significance of elevated soluble interleukin-6 receptor levels in patients with plasma cell disorders. (Letter). British Journal of Haematology, 92, 767-768.
38. Taga, T., Hibi, M., Hirata, Y., Yamasaki, K., Yasukawa, K., Matsuda, T., Hirano, T. & Kishimoto, T. (1989) Interkeukin-6 triggers the association of its receptor with a possible signal transducer, gp130. Cell, 58, 573-581.
39. Uchiyama, H., Barut, B.A., Mohrbacher, A.F., Chauhan, D. & Anderson, K.C. (1993) Adhesion of human myeloma-derived cell lines to bone marrow stromal cells stimulates interleukin-6 secretion. Blood, 82, 3712-3720.
40. Williams, L.M., Gibbons, D.L., Gearing, A., Maini, R.N., Feldmann, M. & Brennan, F.M. (1996) Paradoxical effects of a synthetic metalloproteinase inhibitor that blocks both p55 and p75 TNF receptor shedding and TNFα processing in RA synovial membrane cell cultures. Journal of Clinical Investigation, 97, 2833-2841.
41. Yasukawa, K., Futatsugi, K., Saito, T., Yawata, H., Narazaki, M., Suzuki, U., Taga, T. & Kishimoto, T. (1992) Association of recombinant soluble IL-6-signal transducer, gp 130, with a complex of IL-6 and soluble IL-6 receptor, and establishment of an ELISA for soluble gp130. Immunology Letters, 51, 123-130.
42. Yasukawa, K., Saito, T., Fukunaga, T., Sekimori, Y., Koishihara, Y., Fukui, H., Ohsugi, Y., Matsuda, T., Yawala, H., Hirano, T., Taga, T. & Kishimoto, T. (1990) Purification and characterization of soluble human IL-6 receptor expressed in CHO cells. Journal of Biochemistry, 108, 673-676.